13 results on '"S. Muto"'
Search Results
2. Hyponatremia and hyperreninemic hypoaldosteronism in a critically ill patient: combination of insensitivity to angiotensin II and tubular unresponsiveness to mineralocorticoid
- Author
-
S, Muto, G, Fujisawa, T, Natsume, Y, Asano, T, Yaginuma, S, Hosoda, and T, Saito
- Subjects
Male ,Kidney Tubules ,Adrenocorticotropic Hormone ,Angiotensin II ,Fludrocortisone ,Adrenal Glands ,Renin ,Humans ,Pneumonia ,Middle Aged ,Hypoaldosteronism ,Hyponatremia - Abstract
A 62-year-old man with pneumonia and left flank pain had a clinical syndrome of hyponatremia, hypotension, dehydration, and high urinary sodium excretion in the presence of a normal glomerular filtration rate. The plasma level of antidiuretic hormone was relatively high despite decreased serum osmolality. Thyroid function and excretion of glucocorticoid and sex steroids were normal. The serum aldosterone level was very low despite elevated plasma renin activity. Angiotensin II failed to stimulate any secretion of aldosterone, despite the occurrence of a progressive rise in blood pressure. On the other hand, rapid ACTH administration increased both serum aldosterone and cortisol. The patient showed no effective response to increased salt intake, but large doses of mineralocorticoid resulted in a normal serum sodium level without dehydration. Subsequently, he suffered cardiac arrest secondary to ventricular tachycardia. Postmortem examination showed well differentiated adenocarcinoma in the left pleura and an intact, histologically normal adrenal zona glomerulosa and kidney. This is the first reported case of a critically ill patient with hyponatremia caused by hyperreninemic hypoaldosteronism possibly due to angiotensin II insensitivity and tubular unresponsiveness to mineralocorticoid.
- Published
- 1990
3. Patients with adult minimal change nephrotic syndrome treated with long-term cyclosporine did not experience a reduction in their eGFR.
- Author
-
Inoue M, Yumura W, Morishita Y, Ito C, Hamano Y, Ando Y, Muto S, and Kusano E
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Nephrosis, Lipoid physiopathology, Nephrosis, Lipoid prevention & control, Secondary Prevention, Cyclosporine administration & dosage, Cyclosporine adverse effects, Glomerular Filtration Rate drug effects, Immunosuppressive Agents administration & dosage, Immunosuppressive Agents adverse effects, Nephrosis, Lipoid drug therapy
- Abstract
Background: The long-term efficacy and safety of cyclosporine (CyA) in the treatment of adult minimal change nephrotic syndrome (MCNS) was examined., Methods: The medical record of 15 patients diagnosed with MCNS by renal biopsy and treated with CyA for at least 2 years were reviewed., Results: The mean administration period of CyA was 78.3 months. The mean CyA dose for the induction period was 2.1 ± 0.9 mg/kg and 1.7 ± 1.0 mg/kg for the maintenance period. The mean dose of prednisolone used during the induction period was 20.3 mg and 2.7 mg during the maintenance. The frequency of MCNS relapse was decreased to 0.5 times/year in patients treated with CyA, compared to treatment without CyA (2.4 times/y). Two cases of mild liver damage and 3 cases of elevated blood pressure were observed during the administration of CyA. These adverse effects improved after reducing the CyA dose or treatment with an antihypertensive agent. A decrease in the estimated glomerular filtraion rate (eGFR) was not associated with long-term CyA use., Conclusion: At our institution, patients who were treated for MCNS with CyA for at least 2 years experienced no deterioration in renal function.
- Published
- 2013
- Full Text
- View/download PDF
4. The origin of idiopathic renal arteriovenous malformation with giant twin aneurysms.
- Author
-
Iwazu Y, Muto S, Miyata Y, Ochi M, Tokue A, Asano Y, and Kusano E
- Subjects
- Aneurysm diagnostic imaging, Arteriovenous Malformations diagnostic imaging, Diagnosis, Differential, Female, Humans, Imaging, Three-Dimensional, Middle Aged, Renal Artery diagnostic imaging, Renal Veins diagnostic imaging, Severity of Illness Index, Tomography, X-Ray Computed, Aneurysm congenital, Arteriovenous Malformations diagnosis, Kidney blood supply, Renal Artery abnormalities, Renal Veins abnormalities
- Abstract
A 50-year-old female patient who presented with intermittent gross hematuria was referred to our hospital. Three-dimensional computed tomography (3D-CT) revealed a left renal arteriovenous malformation (AVM). Because she declined to undergo additional therapy including surgical treatment, we observed the clinical course of renal AVM for 7 years using 3DCT. When the 3D-CT showed gradual enlargement of the aneurysms concurrent with the onset of clinical symptoms (cardiomegaly and hypertension), we performed simple left nephrectomy. After the operation, the cardiomegaly and hypertension returned to normal, and gross hematuria did not recur. Based on the macro-anatomical findings of the resected kidney and the observation of the natural course, this case strongly supported the hypothesis that the renal AVM had existed from birth and enlarged gradually to eventually produce the typical signs and symptoms.
- Published
- 2013
- Full Text
- View/download PDF
5. Two cases of renal hypouricemia in which dopamine infusion produced a good recovery from exercise-induced acute kidney injury.
- Author
-
Saito O, Sugase T, Saito T, Akimoto T, Inoue M, Ando Y, Muto S, and Kusano E
- Subjects
- Acute Kidney Injury etiology, Acute Kidney Injury pathology, Adult, Exercise, Humans, Male, Nephrons pathology, Renal Artery physiology, Renal Tubular Transport, Inborn Errors complications, Treatment Outcome, Urinary Calculi complications, Vascular Resistance, Young Adult, Acute Kidney Injury drug therapy, Dopamine therapeutic use, Dopamine Agents therapeutic use, Renal Tubular Transport, Inborn Errors drug therapy, Urinary Calculi drug therapy
- Abstract
We report 2 cases with a good recovery from acute kidney injury (AKI) due to exercise-induced AKI associated with renal hypouricemia. Case 1 involves a 20-yearold man who had a similar episode 1 year earlier. He complained of nausea, vomiting and loin pain after playing football. On admission, his serum creatinine was 3.27 mg/dl and he was treated with intravenous fluid infusion (2 l/d). His renal function deteriorated and creatinine rose to 9.82 mg/dl. A renal hemodynamic evaluation using duplex Doppler ultrasound showed a high arterial resistance index (RI). After we changed his treatment to intravenous continuous infusion of 2 µg/kg/min dopamine, RI decreased sequentially and creatinine decreased without hemodialysis. A renal biopsy performed 7 days after dopamine infusion showed no changes in glomeruli and tubules, suggesting the absence of acute tubular necrosis, and no uric acid crystals or myoglobin casts in tubules. Case 2 involves a 42-year-old man who complained of loin pain after riding a motorcycle. On admission, his creatinine and creatine phosphokinase (CPK) were 3.93 mg/dl and 59 mU/ml, respectively. His RI was also high and he was treated immediately with an intravenous continuous infusion of 2 µg/kg/min dopamine. RI and creatinine decreased sequentially. Both cases suggest the effectiveness of dopamine infusion for AKI due to renal hypouricemia in which the RI of the renal arteries is high.
- Published
- 2011
- Full Text
- View/download PDF
6. Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia.
- Author
-
Onishi A, Muto S, Homma S, Inaba T, Shuto R, Kusano E, and Asano Y
- Subjects
- Aged, Biomarkers blood, Biomarkers urine, Humans, Hydrocortisone urine, Hypocalcemia blood, Hypocalcemia drug therapy, Hypophosphatemia blood, Hypophosphatemia drug therapy, Liddle Syndrome blood, Liddle Syndrome drug therapy, Male, Mineralocorticoid Receptor Antagonists therapeutic use, Renal Tubular Transport, Inborn Errors blood, Renal Tubular Transport, Inborn Errors drug therapy, Renal Tubular Transport, Inborn Errors etiology, Risk Factors, Spironolactone therapeutic use, Time Factors, Treatment Outcome, Up-Regulation, Urinary Calculi blood, Urinary Calculi drug therapy, Urinary Calculi etiology, Glycyrrhizic Acid adverse effects, Hydrocortisone blood, Hypocalcemia etiology, Hypophosphatemia etiology, Liddle Syndrome etiology, Pneumonia complications
- Abstract
We describe here the interesting case of a 73-year-old hypertensive man with pseudoaldosteronism. He had been taking glycyrrhizin at a dose of 75 mg/day for 12 years because of mild liver damage, but had never experienced any previous symptoms associated with hypokalemia. He was referred to our hospital because of hypokalemic tetraparesis and rhabdomyolysis. At that time, we noted mineralocorticoid excess characterized by hypokalemia due to urinary K loss, exacerbation of hypertension due to increased tubular Na reabsorption, metabolic alkalosis, and suppression of both plasma renin activity and plasma aldosterone concentration. His urinary free cortisol excretion rate and the urinary ratio of free cortisol to free cortisone were markedly elevated. Thus we diagnosed pseudoaldosteronism that was related to the long-term use of glycyrrhizin. When he developed pseudoaldosteronism, he also contracted pneumonia, and exhibited elevated levels of serum cortisol and creatinine clearance (CCr) as well as hypouricemia, hypocalcemia, and hypophosphatemia. All normalized after the recovery from pneumonia and the administration of spironolactone. The extracellular volume expansion associated with increased tubular Na reabsorption by the aldosterone-sensitive distal nephron and the resulting increase in CCr caused an inhibition of proximal tubular reabsorption of uric acid, Ca, and inorganic phosphate, leading to their renal loss and therefore hypouricemia, hypocalcemia, and hypophosphatemia, respectively. In this patient, the increased circulating cortisol associated with the stress of inflammation caused by pneumonia triggered the development of pseudoaldosteronism.
- Published
- 2010
7. A case of minimal change nephrotic syndrome with acute renal failure complicating Hashimotoâs disease.
- Author
-
Iwazu Y, Nemoto J, Okuda K, Nakazawa E, Hashimoto A, Fujio Y, Sakamoto M, Ando Y, Muto S, and Kusano E
- Subjects
- Acute Kidney Injury pathology, Acute Kidney Injury therapy, Biopsy, Follow-Up Studies, Humans, Male, Middle Aged, Nephrosis, Lipoid pathology, Nephrosis, Lipoid therapy, Plasmapheresis methods, Acute Kidney Injury etiology, Hashimoto Disease complications, Nephrosis, Lipoid etiology
- Abstract
A 63-year-old man was admitted to our hospital for evaluation of generalized edema. Coexistence of severe hypothyroidism and nephrotic syndrome was detected by laboratory examination. High titer of both antimicrosomal antibody and antithyroid peroxidase antibody indicated Hashimotoâs disease. Renal biopsy showed minimal change glomerular abnormality, but no findings of membranous nephropathy. A series of medical treatments, including steroid therapy, thyroid hormone and human albumin replacement therapy, were administered. However, acute renal failure accompanied by hypotension, was not sufficiently prevented. After 9 sessions of plasmapheresis therapy, the severe proteinuria and low serum albumin levels were improved. Even after resting hypotension was normalized, neither renal function nor thyroid function were fully recovered. After discharge, renal function gradually returned to normal, and the blood pressure developed into a hypertensive state concomitant with the normalization of thyroid function. This report is a rare case of autoimmune thyroid disease complicated with minimal change nephrotic syndrome. In most cases of nephritic syndrome, acute renal failure (ARF) has been reported to coexist with hypertension. Although pseudohypothyroidism is well-known in nephrotic pathophysiology, complications of actual hypothyroidism are uncommon. It is suggested that the development of hypotension and ARF could be enhanced not only by hypoproteinemia, but also by severe hypothyroidism.
- Published
- 2008
- Full Text
- View/download PDF
8. Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy.
- Author
-
Kobayashi T, Ando Y, Umino T, Miyata Y, Muto S, Hironaka M, Asano Y, and Kusano E
- Subjects
- Adolescent, Biopsy, Humans, Kidney pathology, Kidney ultrastructure, Male, Proteinuria therapy, Remission Induction methods, Secondary Prevention, Serum Albumin analysis, Blood Component Removal methods, Nephrosis, Lipoid therapy
- Abstract
We report a case of a 17-year-old male with relapse of minimal-change nephrotic syndrome (MCNS), in whom apheresis monotherapy without steroids or immunosuppressants resulted in complete remission. The patient initially developed nephrotic syndrome in February 1998. The first renal biopsy confirmed the diagnosis of MCNS. The patient was also found to be a carrier of hepatitis B virus. Steroid therapy was started with oral prednisolone 60 mg/day. Complete remission was achieved in 3 months, and the steroid treatment was tapered off in May 2001. During the steroid tapering, temporal exacerbation of liver function was noted. In July 2002, the patient was admitted to our hospital again due to relapse of nephrotic syndrome. Second biopsy reconfirmed the diagnosis of MCNS. Since the serum titer of HBV was elevated, apheresis monotherapy was selected to avoid the risk of steroid-induced fulminant hepatitis. Four sessions of low-density lipoprotein apheresis (LDL-A) and 5 sessions of double-filtration plasmapheresis (DFPP) reduced the proteinuria from 9.2 g/day to 0.2 g/day over 38 days without any additional medication. Proteinuria remained suppressed below 0.2 g/day for more than 12 months and no exacerbation of liver function was observed up to the final follow-up in September 2003. The present case suggested the potential of apheresis monotherapy to induce and maintain complete remission of MCNS and an important role of circulating factors in the pathogenesis of MCNS.
- Published
- 2006
- Full Text
- View/download PDF
9. Fanconi's syndrome and distal (type 1) renal tubular acidosis in a patient with primary Sjögren's syndrome with monoclonal gammopathy of undetermined significance.
- Author
-
Kobayashi T, Muto S, Nemoto J, Miyata Y, Ishiharajima S, Hironaka M, Asano Y, and Kusano E
- Subjects
- Acidosis, Renal Tubular diagnosis, Biopsy, Female, Humans, Kidney pathology, Kidney ultrastructure, Middle Aged, Acidosis, Renal Tubular complications, Fanconi Syndrome diagnosis, Paraproteinemias diagnosis, Sjogren's Syndrome blood, Sjogren's Syndrome complications
- Abstract
Tubulointerstitial nephritis is a well-recognized complication in primary Sjögrens syndrome. Fanconi's syndrome is a far less frequent complication compared with distal tubular dysfunction. We here describe a 49-year-old woman with primary Sjögren's syndrome. In 1997, she was diagnosed with primary Sjögren's syndrome with tubulointerstitial nephritis, and was then treated with oral prednisolone for the tubulointerstitial nephritis. In 2002, she was referred to our hospital because of progressive fatigue. At that time, biclonal spike on serum protein (IgG-kappa and IgA-kappa) and Bence-Jones protein in urine were found. Bone marrow aspiration showed 1.0% plasma cell infiltration. Thus, a diagnosis of monoclonal gammopathy of undetermined significance (MGUS) was made. In 2004, she was again admitted to our hospital because of mild renal dysfunction and hypokalemia. Laboratory evaluation showed inappropriate, alkaline urine in hyperchloremic metabolic acidosis and a positive urine anion gap, indicating the presence of distal (Type 1) renal tubular acidosis (RTA). The urine concentration defect was also found. Further studies revealed proximal tubular dysfunction, including renal glycosuria, generalized aminoaciduria, phosphaturia, uricosuria and proximal RTA. The kidney biopsy represented diffuse and severe tubulointerstitial nephritis with dense infiltrates of lymphocytes and IgA and K light chain-positive plasma cells. No findings of multiple myeloma or malignant lymphoma were observed. In conclusion, our patient had Sjögren's syndrome with MGUS and exhibited dysfunction of both proximal tubule (Fanconi's syndrome) and distal tubule, which may be attributed to diffuse tubulointerstitial nephritis.
- Published
- 2006
- Full Text
- View/download PDF
10. Reversible hypocalcemic heart failure with T wave alternans and increased QTc dispersion in a patient with chronic renal failure after parathyroidectomy.
- Author
-
Iwazu Y, Muto S, Ikeuchi S, Yanagiba S, Miyata Y, Asano Y, and Kusano E
- Subjects
- Calcium blood, Female, Humans, Hypocalcemia etiology, Hypocalcemia physiopathology, Hypokalemia etiology, Magnesium blood, Middle Aged, Postoperative Complications, Potassium blood, Stroke Volume, Electrocardiography, Heart Failure etiology, Heart Failure physiopathology, Hypocalcemia complications, Kidney Failure, Chronic complications, Parathyroidectomy
- Abstract
Despite the crucial role of calcium in myocardial contractility, hypocalcemia has very rarely been reported as a reversible cause of heart failure. In this article, we describe a case of a 51-year-old woman with advanced stages of chronic renal failure after parathyroidectomy who exhibited congestive heart failure, severe hypocalcemia, hypomagnesemia and hypokalemia. Severe hypocalcemia resulted from discontinuation of taking calcium supplements after parathyroidectomy and from reduced 1.25(OH)2D3 synthesis by damaged kidneys. The patient presented with reduced left ventricular ejection fraction (EF) and ECG abnormalities (T wave alternans and increased QTc dispersion), both of which improved after correction of serum calcium levels. Her serum levels of total calcium corrected for serum albumin, but not serum levels of magnesium or potassium, positively and negatively correlated with EF and QTc dispersion, respectively. In the present case, both heart failure and the ECG abnormalities are directly associated with hypocalcemia.
- Published
- 2006
- Full Text
- View/download PDF
11. Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient.
- Author
-
Takahashi H, Muto S, Nakazawa E, Yanagiba S, Masunaga Y, Miyata Y, Tamba K, Kusano E, Matsuo M, Matsuo T, and Asano Y
- Subjects
- Adult, Benzamidines, Extracorporeal Circulation, Heparin therapeutic use, Humans, Male, Anticoagulants therapeutic use, Aspirin therapeutic use, Guanidines therapeutic use, Heparin adverse effects, Platelet Aggregation Inhibitors therapeutic use, Renal Dialysis, Thrombocytopenia prevention & control
- Abstract
We report on the management of a 36-year-old hemodialysis patient with heparin-induced thrombocytopenia (HIT, type II) and clot formation in extracorporeal circulation. Platelet aggregation test and measurement of anti-platelet factor 4/heparin complex antibody by enzyme-linked immunosorbent assay revealed to us that our patient had developed HIT. Instead of heparin, we used nafamostat mesilate (NM) as an anticoagulant during hemodialysis, but could not completely prevent HIT-induced thrombocytopenia or clot formation in the extracorporeal circuit. Combined use of NM and aspirin completely inhibited platelet aggregation, decrease in platelet count and clot formation in the extracorporeal circuit.
- Published
- 2003
- Full Text
- View/download PDF
12. Hyperreninemic hypoaldosteronism due to hepatocellular carcinoma metastatic to the adrenal gland.
- Author
-
Otabe S, Muto S, Asano Y, Sato K, Ohtani M, Kawamoto C, Ido K, and Kimura K
- Subjects
- Adrenocorticotropic Hormone pharmacology, Aldosterone blood, Angiotensin II pharmacology, Furosemide pharmacology, Humans, Hypoaldosteronism blood, Male, Middle Aged, Renin antagonists & inhibitors, Adrenal Gland Neoplasms secondary, Carcinoma, Hepatocellular secondary, Hypoaldosteronism etiology, Liver Neoplasms, Renin blood
- Abstract
Metastases to the adrenal glands are common in patients with cancer, but among those affected, hyperreninemic hypoaldosteronism is noted very rarely. A case of hyperreninemic hypoaldosteronism secondary to metastatic hepatocellular carcinoma is reported. Laboratory data revealed selective aldosterone deficiency with hyperreninemia. Biopsy documented replacement of the adrenal glands with metastatic hepatocellular carcinoma. A review of the literature disclosed that the present case was an extremely rare one of its kind.
- Published
- 1991
13. Hyponatremia and hyperreninemic hypoaldosteronism in a critically ill patient: combination of insensitivity to angiotensin II and tubular unresponsiveness to mineralocorticoid.
- Author
-
Muto S, Fujisawa G, Natsume T, Asano Y, Yaginuma T, Hosoda S, and Saito T
- Subjects
- Humans, Hyponatremia drug therapy, Male, Middle Aged, Pneumonia complications, Adrenal Glands drug effects, Adrenocorticotropic Hormone therapeutic use, Angiotensin II therapeutic use, Fludrocortisone therapeutic use, Hypoaldosteronism complications, Hyponatremia etiology, Kidney Tubules drug effects, Renin blood
- Abstract
A 62-year-old man with pneumonia and left flank pain had a clinical syndrome of hyponatremia, hypotension, dehydration, and high urinary sodium excretion in the presence of a normal glomerular filtration rate. The plasma level of antidiuretic hormone was relatively high despite decreased serum osmolality. Thyroid function and excretion of glucocorticoid and sex steroids were normal. The serum aldosterone level was very low despite elevated plasma renin activity. Angiotensin II failed to stimulate any secretion of aldosterone, despite the occurrence of a progressive rise in blood pressure. On the other hand, rapid ACTH administration increased both serum aldosterone and cortisol. The patient showed no effective response to increased salt intake, but large doses of mineralocorticoid resulted in a normal serum sodium level without dehydration. Subsequently, he suffered cardiac arrest secondary to ventricular tachycardia. Postmortem examination showed well differentiated adenocarcinoma in the left pleura and an intact, histologically normal adrenal zona glomerulosa and kidney. This is the first reported case of a critically ill patient with hyponatremia caused by hyperreninemic hypoaldosteronism possibly due to angiotensin II insensitivity and tubular unresponsiveness to mineralocorticoid.
- Published
- 1990
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.